Human embryonic stem cells in the treatment of patients with spinal cord injury

Annals of Neurosciences

Volumn 22, Issue 4, 2015, Pages 208-216

  Shroff, Geeta ^a   Gupta, Rakesh ^b  

^a Nutech Mediworld   (India)

^b INDRAPRASTHA APOLLO HOSPITAL   (India)

Author keywords

HESC; Paraplegia; Quadriplegia; Stem cell therapy

Indexed keywords

ADULT; ARM MOVEMENT; ARTICLE; BODY EQUILIBRIUM; CLINICAL ARTICLE; DISEASE DURATION; EMBRYONIC STEM CELL TRANSPLANTATION; FEMALE; HUMAN; LEG MOVEMENT; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; PATIENT SAFETY; QUADRIPLEGIA; SITTING; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; THERAPY EFFECT; TRACTOGRAPHY; TREATMENT OUTCOME; TREATMENT PLANNING; YOUNG ADULT;

EID: 84928817212     PISSN: 09727531     EISSN: 09763260     Source Type: Journal    
DOI: 10.5214/ans.0972.7531.220404     Document Type: Article

References (22)

1. Lukovic D, Moreno Manzano V, et al. Concise review: human pluripotent stem cells in the treatment of spinal cord injury. Stem Cells. 2012; 30(9): 1787-92.
2. Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976). 2001; 26(24 Suppl): S2-12.
3. Ning GZ, Wu Q, Li YL, et al. Epidemiology of traumatic spinal cord injury in Asia: a systematic review. J Spinal Cord Med. 2012; 35(4): 229-39.
4. Erceg S, Ronaghi M, Oria M, et al. Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem Cells. 2010; 28(9): 1541-9.
5. Keirstead HS, Nistor G, Bernal G, et al. Human embryonic stem cellderived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci. 2005; 25(19): 4694-705.
6. Lee H, Shamy GA, Elkabetz Y, et al. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells. 2007; 25(8): 1931-9.
7. Park HC, Shim YS, Ha Y, et al. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng. 2005; 11(5-6): 913-22.
8. Lima C, Escada P, Pratas-Vital J, et al. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair. 2010; 24(1): 10-22.
9. American Spinal Injury Association/International Medical Society of Paraplegia (ASIA/IMSOP) International Standards for Neurological and Functional Classification of Spinal Cord Injury patients (Revised). Chicago, IL: American Spinal Injury Association. 1996.
10. House of Lords SATSC. Available from http://www.parliament.uk/documents/ lords-committees/science-technology/RegenerativeMedicine/ RegenMed.pdf ; accessed on 26 September 2014.
11. Fawcett JW. Overcoming inhibition in the damaged spinal cord. J Neurotrauma. 2006; 23(3-4): 371-83.
12. Baptiste DC, Fehlings MG. Update on the treatment of spinal cord injury. Prog Brain Res. 2007; 161: 217-33.
13. Azmoon S, Demarest C, Pucillo AL, et al. Neurologic and cardiac benefits of therapeutic hypothermia. Cardiol Rev. 2011; 19(3): 108-14.
14. Ware CB, Nelson AM, Mecham B, et al. Derivation of naive human embryonic stem cells. Proc Natl Acad Sci U S A. 2014; 111(12): 4484-9.
15. Barnabe-Heider F, Frisen J. Stem cells for spinal cord repair. Cell Stem Cell. 2008; 3(1): 16-24. Epub 2008/07/03.
16. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981; 78(12): 7634-8. Epub 1981/12/01.
17. Nistor GI, Totoiu MO, Haque N, et al. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia. 2005; 49(3): 385-96. Epub 2004/11/13.
18. Kakinohana O, Juhasova J, Juhas S, et al. Survival and differentiation of human embryonic stem cell-derived neural precursors grafted spinally in spinal ischemia-injured rats or in naive immunosuppressed minipigs: a qualitative and quantitative study. Cell Transplant. 2012; 21(12): 2603-19.
19. Lukovic D, Stojkovic M, Moreno-Manzano V,et al. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron's clinical trial for spinal cord injury. Stem Cells Dev. 2014; 23(1): 1-4.
20. MedlinePlus. Available at; http://www.nlm.nih.gov/medlineplus/ency/ article/002398.htm. Accessed 29 August, 2014.
21. Kang SK, Shin IS, Ko MS, et al. Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int. 2012; 2012: 342968.
22. Borlongan CV, Glover LE, Tajiri N, et al. The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Prog Neurobiol. 2011; 95(2): 213-28.